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A mosaic maternal splice donor mutation in the
EHMT1 gene leads to aberrant transcripts and
to Kleefstra syndrome in the offspring
Andreas Rump1, Laura Hildebrand1, Andreas Tzschach2,3, Reinhard Ullmann3, Evelin Schrock1 and
Diana Mitter*,4
The euchromatic histone-lysine N-methyltransferase 1 (EHMT1) gene was examined in a 3-year-old boy with characteristic
clinical features of Kleefstra syndrome. Sequencing of all 27 EHMT1 exons revealed a novel mutation,
NM_024757.4:c.2712þ1G4A, which affects the splice donor of intron 18. Whereas the index patient is heterozygous
for that mutation, his phenotypically normal mother shows tissue-specific mosaicism. Sequencing of EHMT1 RT-PCR products
revealed two aberrant transcript variants: in one variant, exon 18 was skipped; in the other, a near-by GT motif was used as
splice donor and intronic sequence was inserted between exons 18 and 19. Both transcript variants were found in the patient
and his mother. The latter had lower amounts of these transcripts consistent with mosaic status. This is the first description of
an EHMT1 point mutation being inherited from a parent with verified mosaicism. The constitutive c.2712þ1G4A splice site
mutation in EHMT1 is fully pathogenic, and the transcript variants produced do not attenuate the severity of the disease.
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INTRODUCTION
Kleefstra syndrome (OMIM 610253)1 is characterized by moderate-
to-severe intellectual disability, childhood hypotonia, and distinctive
facial features. Additional clinical findings include heart defects, renal/
urological defects, genital defects in males, autistic-like behavior in
childhood, and extreme apathy or catatonic-like features after
puberty.2 The genetic causes of Kleefstra syndrome are heterozygous
microdeletions in 9q34.3 and EHMT1 (euchromatic histone-lysine
N-methyltransferase 1) point mutations, both leading to loss of
function of the affected EHMT1 allele.1,3 Parent-to-child transmission
of Kleefstra syndrome appears to be very rare and was described only
for three cases with 9q34.3 deletion4,5 and one case with a balanced
translocation.5 All EHMT1 point mutations described so far have
appeared de novo in the patients.6
Here, we report on a patient with characteristic features of Kleefstra
syndrome carrying a novel splice-site mutation in EHMT1. The




This boy (Figure 1) was the first child born to caucasion non-consanguineous
parents, a 19-year-old woman (Figure 1) and a 22-year-old man. No fetal
abnormalities were recorded during pregnancy. The boy was born sponta-
neously after 36 weeks of pregnancy with a birth weight of 2370 g (0.9 SD),
length 43 cm (2.4 SD), and head circumference 31 cm (1.8 SD). At birth, a
neonatal tooth was noted, which fits into the phenotypic spectrum observed in
patients with Kleefstra syndrome.7 In addition, the boy showed apnoeic
episodes with bradycardia, hyperbilirubinemia, anemia, and neutropenia.
Echocardiography was normal. At the age of 1 month, bilateral incarcerated
inguinal hernia was corrected. Early development was complicated by failure to
thrive and recurrent infections.
On examination at the age of 3 years 10 months, his length was 103 cm
(mean), weight 18 kg (1.1 SD), and head circumference 47 cm (2.9 SD). He
showed brachymicrocephaly, characteristic facial dysmorphism (Figure 1), and
tapering fingers. He presented with muscular hypotonia. His motor and speech
development were delayed. He learned to sit at the age of 12 months and to
walk at the age of 24 months. He did not speak but showed relatively good
comprehension skills. He showed autistic-like features and autoaggression. An
MRI scan of the brain at the age of 3 years 2 months showed mild
periventricular gliosis. EEG and hearing test were normal. Ophthalmological
examination showed hypermetropia.
Cytogenetic analysis
Standard cytogenetic analysis8 was performed on cultured lymphocytes with
G-banding techniques at a resolution of 450–500 bands per haploid genome.
Fluorescence in situ hybridization with probe TelVysion 9q SpectrumOrange
(Abbott Laboratories, Abbott Park, IL, USA) was performed.
Array CGH analysis
CGH analysis was performed on the 400K Oligonucleotide Array (Agilent
Technologies, Santa Clara, CA, USA), according to the manufacturer’s
instructions. Data were analyzed using the CGHPRO software (Ullmann,
Berlin, Germany).
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Mutation analysis on genomic level
Genomic DNA was derived from peripheral blood and oral mucosa. The 27
EHMT1 exons defined by RefSeq entry NM_024757.4, and flanking intronic
regions were PCRamplified and sequenced using the BigDye-terminator
chemistry (Applied Biosystems Deutschland GmbH, Darmstadt, Germany).
Mutation analysis on cDNA level
Total RNA from short-term cultivated lymphocytes was isolated with PAXgene
Blood RNA Kit (Qiagen, Hilden, Germany). Using the SuperScript VILO
cDNA synthesis kit (Invitrogen, Darmstadt, Germany), 1mg total RNA was
transcribed to first-strand cDNA with random primers provided by the
supplier. Amplification and sequencing of EHMT1 cDNA was conducted with
primers specific for exons 15 (ex15F, CACCAGAATAAGCGCTCTC) and 20
(ex20R, GGCGTCTCTCCTTCCTTGTT). Obtained sequences were compared
with reference sequence (UCSC, GRCh37/hg19 assembly).
RESULTS
Cytogenetic, molecular cytogenetic, and array CGH analysis
Conventional cytogenetic analysis of the patient revealed a normal
male karyotype. Fluorescence in situ hybridization analysis showed
normal signals. Array CGH analysis revealed no potentially patho-
genic copy number variations.
Mutation analysis of EHMT1
Sequencing of the exon-targeted EHMT1-amplicons revealed a novel
G-to-A transition (NM_024757.4:c.2712þ 1G4A) abolishing the
invariable consensus GT splice donor of intron 18 (Figure 2a) in
the patient and his mother. Although the patient carries this mutation
in a clearly heterozygous state, his mother shows mosaicism in
peripheral blood (Figure 2b). Within her oral mucosa, the mutation
was below detection level. The father and the younger brother of the
patient did not carry the mutation. To determine the effect of the
c.2712þ 1G4A point mutation on splicing, total RNA of the patient
and his parents was obtained from peripheral blood. A cDNA-portion
of EMHT1, spanning exons 15–20, was amplified. Sequencing
revealed three different transcripts (Figure 2c): besides the normal
EHMT1 transcript produced by all family members (Figure 2c),
mother and son uniquely express two additional aberrant transcripts.
The first transcript results from the misapplication of a GT-
dinucleotide, which resides 4 bp upstream of the original splice donor
(Figure 2a). As a consequence, the resulting transcript contains four
additional nucleotides between exons 18 and 19. The second aberrant
transcript is the result of exon skipping of exon 18. This transcript
produces a PCR-product that is 105 bp shorter than the amplicon
from normal cDNA (data not shown). According to Bioanalyzer
quantification, the exon 17/19 fusion represented 13.6% of the total
PCR product obtained from the patient’s cDNA and 10.1% of the
total PCR product obtained from the maternal cDNA. To separate the
‘exon 18þ 4 bp’-PCR-product, we sequenced the RT-PCR product
mixture and compared the peak heights of the ‘exon 18þ 4 bp’-PCR-
product with the peaks that are attributed to the normal transcript. In
the patient, the aberrant ‘exon 18þ 4 bp’-PCR product constitutes
approximately 20% of the total RT-PCR product, in the mother
roughly 10%.
DISCUSSION
We report on a patient with Kleefstra syndrome and a novel EHMT1
splice-site mutation. The c.2712þ 1G4A mutation has at least two
different consequences at mRNA level. We detected two different
splice variants. One variant contains 4 bp of intronic sequence and
is very likely to create a non-functional truncated EHMT1 protein.
The other variant is more interesting: as skipping of exon 18 does
not disrupt the reading frame, the resulting mRNA theoretically
has the potential to produce a near-full length EHMT1 protein with
just 35 amino acids missing (p.(Asp870_Asn904del)). This protein
variant would lack ANK5, the fifth of eight consecutive ankyrin
repeats in EHMT1.9 Given the fact that the patient displays
the characteristic clinical features of Kleefstra syndrome, we have
to conclude that the near-full length EHMT1 protein variant, if
produced at all, is either not stable in the cells or not capable to
attenuate pathogenicity.
The detection of mosaicism for a loss-of-function mutation in
EHMT1 in the healthy mother indicates that Kleefstra syndrome is
Figure 1 Facial phenotype. (a) Patient at the age of 3 years 1 month, (b, c) at 3 years 10 months, and (d) at 4 years 4 months. Facial dysmorphism
includes anteverted nares, thin upper lip, everted lower lip, large mouth, and flat mid face. (e) Hands show tapering fingers. (f, g) Mother of the patient at
the age of 23 years with mild facial dysmorphism, including upslanting palpebral fissures, thin upper lip, and flat midface. The colour reproduction of this
figure is available at the European Journal of Human Genetics online.
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not created unless a high degree of mosaicism is reached and/or
certain tissues are affected. This is in line with observations made for
a mosaic carrier of the 9q34.3 deletion, where 80% of the cells in a
buccal swab sample carried a partial deletion of the EHMT1 gene.4 As
the clinical features of Kleefstra syndrome involve tissues developing
from different germ layers, a non-inherited (i.e. post-zygotic)
Kleefstra syndrome causing mutation probably needs to occur in
the very early stages of development in a cell that contributes to both
germline and somatic tissues. Unfortunately, there is no way to infer
the degree of germline mosaicism from the extent of somatic
mosaicism within an individual. But as shown recently for two
siblings with Pitt–Hopkins syndrome,10 a high degree of somatic
mosaicism in a carrier bears the risk of familial recurrence in the
offspring. Therefore, parents of a child with Kleefstra syndrome
should always be checked for mosaicism for the respective mutation.
In cases, where parental mosaicism is observed, the increased risk of
familial recurrence has to be addressed within the genetic counseling
of those families.
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